Optimind Pharma Corp. (CSE:OMND)
Canada · Delayed Price · Currency is CAD 0.0050
-0.0050 (-50.00%)
Aug 19, 2025, 1:59 PM EST
Optimind Pharma Revenue
In the fiscal year ending February 28, 2026, Optimind Pharma had annual revenue of 121.29K CAD with 2.47% growth. Optimind Pharma had revenue of 24.51K in the quarter ending February 28, 2026, a decrease of -29.36%.
Revenue
121.29K
Revenue Growth
+2.47%
P/S Ratio
4.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
515.74K
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2026 | 121.29K | 2.93K | 2.47% |
| Feb 28, 2025 | 118.37K | -4.59K | -3.73% |
| Feb 29, 2024 | 122.96K | -47.15K | -27.72% |
| Feb 28, 2023 | 170.11K | 70.42K | 70.64% |
| Feb 28, 2022 | 99.69K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vibe Growth | 25.35M |
| Aequus Pharmaceuticals | 918.47K |
| Ovation Science | 65.81K |
| Genix Pharmaceuticals | 68.00 |
| Planet Based Foods Global | -356.97K |
| Captor Capital | -1.12M |